Reference health

Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation

https://doi.org/10.1016/j.jacc.2014.09.028
CiteStamped reference-health badge
37/37 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 37 checked references that resolve
resolves10.1001/jama.285.18.2370
Prevalence of Diagnosed Atrial Fibrillation in Adults
resolves10.1161/CIRCULATIONAHA.105.595140
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
resolves10.1001/archinternmed.2012.878
The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia
resolves10.1161/CIRCULATIONAHA.108.830042
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
resolves10.1016/j.jacc.2006.08.060
Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial Fibrillation
resolves10.1001/jama.292.20.2471
Obesity and the Risk of New-Onset Atrial Fibrillation
resolves10.1016/j.jacc.2010.08.641
Alcohol Consumption and Risk of Atrial Fibrillation
resolves10.1016/j.hrthm.2011.12.016
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design
resolves10.1001/jama.293.21.2634
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation
resolves10.1001/jama.2009.2029
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
resolves10.1016/j.jacc.2006.08.037
A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
resolves10.1161/CIRCULATIONAHA.108.772582
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
resolves10.1016/j.jacc.2010.05.061
Catheter Ablation for Atrial Fibrillation
resolves10.1161/CIRCULATIONAHA.110.946806
Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation
resolves10.1016/j.hrthm.2014.02.003
Very long-term outcome after initially successful catheter ablation of atrial fibrillation
resolves10.1161/JAHA.112.004549
Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis
resolves10.1111/j.1540-8167.2008.01101.x
Long‐Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late Recurrence
resolves10.1111/j.1540-8167.2008.01118.x
Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial Fibrillation
resolves10.1016/j.jacc.2011.11.051
Impact of Metabolic Syndrome on Procedural Outcomes in Patients With Atrial Fibrillation Undergoing Catheter Ablation
resolves10.1161/01.CIR.0000020190.45892.75
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
resolves10.1016/j.jacc.2008.11.054
Paroxysmal Lone Atrial Fibrillation Is Associated With an Abnormal Atrial Substrate
resolves10.1016/S0735-1097(00)00886-X
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy
resolves10.1016/j.hrthm.2010.01.017
Outcomes of long-standing persistent atrial fibrillation ablation: A systematic review
resolves10.1016/j.hrthm.2011.11.013
Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation
resolves10.1161/CIRCULATIONAHA.104.533190
Response of Atrial Fibrillation to Pulmonary Vein Antrum Isolation Is Directly Related to Resumption and Delay of Pulmonary Vein Conduction
resolves10.1161/01.CIR.0000151289.73085.36
Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins
resolves10.1016/j.jacc.2013.03.052
Treatment of Obstructive Sleep Apnea Reduces the Risk of Atrial Fibrillation Recurrence After Catheter Ablation
resolves10.1016/j.jacc.2010.11.045
Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome
resolves10.1016/j.jacc.2010.02.029
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
resolves10.1016/j.hrthm.2010.05.010
Hypertension and atrial fibrillation: Evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model
resolves10.1016/j.hrthm.2012.08.043
Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation
resolves10.1016/j.hrthm.2011.10.017
Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation
resolves10.1046/j.1540-8167.2002.00135.x
Clinical Evaluation of a Policy of Early Repeated Internal Cardioversion for Recurrence of Atrial Fibrillation
resolves10.3109/08037051.2010.481811
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study
resolves10.1161/01.CIR.0000022665.18619.83
Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation
resolves10.1016/j.jacc.2009.10.046
Reverse Remodeling of the Atria After Treatment of Chronic Stretch in Humans
resolves10.1001/jama.2013.280521
Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
The 2 references without a DOI — listed, not checked
no DOI — not checkedPulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up
no DOI — not checked10.1016/j.jacc.2014.09.028_bib22
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.jacc.2014.09.028"><img src="https://citestamp.com/citestamped/10.1016/j.jacc.2014.09.028/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.jacc.2014.09.028/badge.svg)](https://citestamp.com/citestamped/10.1016/j.jacc.2014.09.028)